Carine Paturel

Carine Paturel

Company: Innate Pharma

Job title: Senior Director, Program & Portfolio Strategy


IPH5301, A Differentiated Therapeutic Antibody Targeting Membrance & Soluble CD73, Unleash Anti-Tumor Immune Response In Combination With Cancer Therapies 3:45 pm

• Demonstrating IPH5301 differentiated Mode of Action on both membrane and soluble CD73, resulting in optimal restoration of immune response • Highlighting preclinical safety and activity for IPH5301 in animal models • Discussing First in Human phase 1 trialRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.